Plasmid profiles and antibiotic susceptibility patterns of Lactobacillus isolated from fermented foods in Nigeria von Olukoya, D.K., Ebigwei, S.I., Adebawo, O.O., Osiyemi, F.O.

Volltext

Use of Sudan Black as an Indicator of Vitamin D on Thin-layer Chromatograms von OSIYEMI, F. O

Volltext

The Conjugation of Indolylacetic Acid in Man, Monkeys and other Species von Bridges, J. W., Evans, Marion E., Idle, J. R., Millburn, P., Osiyemi, F. O., Smith, R. L., Williams, R. T.

Volltext

The effect of testosterone on the biliary excretion of tartrazine in female rats von Hirom, P C, Millburn, P, Osiyemi, F O, Smith, R L, Turbert, H B, Williams, R T

Volltext

The biological effects of the bark ofSaccoglottis Gabonensis urban (Humiriaceae) on microorganisms von Faparusi, S. I., Osiyemi, F. O.

Volltext

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients von Gottlieb, Robert L, Vaca, Carlos E, Paredes, Roger, Mera, Jorge, Webb, Brandon J, Perez, Gilberto, Oguchi, Godson, Ryan, Pablo, Nielsen, Bibi U, Brown, Michael, Hidalgo, Ausberto, Sachdeva, Yessica, Mittal, Shilpi, Osiyemi, Olayemi, Skarbinski, Jacek, Juneja, Kavita, Hyland, Robert H, Osinusi, Anu, Chen, Shuguang, Camus, Gregory, Abdelghany, Mazin, Davies, Santosh, Behenna-Renton, Nicole, Duff, Frank, Marty, Francisco M, Katz, Morgan J, Ginde, Adit A, Brown, Samuel M, Schiffer, Joshua T, Hill, Joshua A

Volltext

The Conjugation of Indolylacetic Acid in Man, Monkeys and Other Species von Bridges, J. W., Evans, Marion E., Idle, J. R., Millburn, P., Osiyemi, F. O., Smith, R. L., Williams, R. T.

Volltext

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 9... von Hagins, D, Orkin, C, Daar, ES, Mills, A, Brinson, C, DeJesus, E, Post, FA, Morales‐Ramirez, J, Thompson, M, Osiyemi, O, Rashbaum, B, Stellbrink, H‐J, Martorell, C, Liu, H, Liu, Y‐P, Porter, D, Collins, SE, SenGupta, D, Das, M

Volltext

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV von Ferenci, Peter, Bernstein, David, Lalezari, Jacob, Cohen, Daniel, Luo, Yan, Cooper, Curtis, Tam, Edward, Marinho, Rui T, Tsai, Naoky, Nyberg, Anders, Box, Terry D, Younes, Ziad, Enayati, Pedram, Green, Sinikka, Baruch, Yaacov, Bhandari, Bal Raj, Caruntu, Florin Alexandru, Sepe, Thomas, Chulanov, Vladimir, Janczewska, Ewa, Rizzardini, Giuliano, Gervain, Judit, Planas, Ramon, Moreno, Christophe, Hassanein, Tarek, Xie, Wangang, King, Martin, Podsadecki, Thomas, Reddy, K. Rajender

Volltext

Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabin... von Orkin, Chloe, Molina, Jean-Michel, Negredo, Eugenia, Arribas, José R, Eron, Joseph J, Van Landuyt, Erika, Lathouwers, Erkki, Hufkens, Veerle, Petrovic, Romana, Vanveggel, Simon, Ajana, F, Arribas, JR, Bailey, J, Benson, P, Bhatti, L, Blaxhult, A, Brar, I, Bredeek, UF, Brinson, C, Brunetta, J, Casado, J, Clarke, A, Conway, B, Cotte, L, de Vente, J, DeJesus, E, Dietz, C, Dretler, R, Eron, J, Fehr, J, Felizarta, F, Flamholc, L, Florence, E, Gallant, J, Gasiorowski, J, Gatell, JM, Gathe, J, Gazzard, BG, Girard, P-M, Gisslèn, M, Gutierrez, F, Gutierrez, MDM, Hagins, D, Halota, W, Henn, S, Henry, WK, Horban, A, Huhn, G, Iribarren, JA, Jain, M, Johnson, MA, Katlama, C, Klein, M, Knobel, H, Lucasti, C, Martorell, C, McDonald, C, Mills, A, Molina, J-M, Morales-Ramirez, J, Mounzer, K, Moutschen, M, Murphy, D, Nahass, R, Negredo, E, Olivet, H, Orkin, C, Osiyemi, O, Perez-Valero, I, Pineda, JA, Podzamczer, D, Portilla Sogorb, J, Post, F, Prelutsky, D, Pulido, F, Rachlis, A, Raffi, F, Rashbaum, B, Rauch, A, Rey, D, Reynes, J, Ricart, C, Richmond, G, Rivero, A, Ruane, P, Gil, I Santos, Scarsella, A, Shafran, S, Shalit, P, Shamblaw, D, Slim, J, Stoeckle, M, Tashima, K, Ustianowski, A, Van Wijngaerden, E, Vandercam, B, Walmsley, S, Wilkin, A, Witor, A, Yazdanpanah, Y

Volltext

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial von Eron, Joseph J, Prof, Rockstroh, Jürgen K, MD, Reynes, Jacques, Prof, Andrade-Villanueva, Jaime, MD, Ramalho-Madruga, Jose Valdez, MD, Bekker, Linda-Gail, MD, Young, Benjamin, MD, Katlama, Christine, MD, Gatell-Artigas, Jose Maria, MD, Arribas, Jose R, MD, Nelson, Mark, MD, Campbell, Havilland, BS, Zhao, Jing, PhD, Rodgers, Anthony J, MS, Rizk, Matthew L, PhD, Wenning, Larissa, PhD, Miller, Michael D, PhD, Hazuda, Daria, PhD, DiNubile, Mark J, MD, Leavitt, Randi, MD, Isaacs, Robin, MD, Robertson, Michael N, MD, Sklar, Peter, MD, Nguyen, Bach-Yen, Dr

Volltext

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate... von Eron, Joseph J., Orkin, Chloe, Cunningham, Douglas, Pulido, Federico, Post, Frank A., De Wit, Stéphane, Lathouwers, Erkki, Jezorwski, John, Petrovic, Romana, Brown, Kimberley, Van Landuyt, Erika, Opsomer, Magda, De Wit, S., Florence, E., Van Wijngaerden, E., Vandercam, B., Brunetta, J., Klein, M., Murphy, D., Rachlis, A., Shafran, S., Walmsley, S., Ajana, F., Cotte, L., Girardy, P.-M., Katlama, C., Molina, J.-M., Poizot-Martin, I., Raffi, F., Rey, D., Reynes, J., Teicher, E., Yazdanpanah, Y., Gasiorowski, J., Piekarska, A., Witor, A., Arribas, J.R., Perez-Valero, I., Casado, J., Gatell, J.M., Gutierrez, F., Galindo, M.J., Gutierrez, M.D.M., Iribarren, J.A., Knobel, H., Negredo, E., Pineda, J.A., Podzamczer, D., Sogorb, J.Portilla, Pulido, F., Ricart, C., Rivero, A., Santos Gil, I., Blaxhult, A., Flamholc, L., Gisslèn, M., Thalme, A., Rauch, A., Stoeckle, M., Gazzard, B.G., Post, F., Ustianowski, A., Bailey, J., Benson, P., Bhatti, L., Brar, I., Bredeek, U.F., Brinson, C., Dietz, C., Dretler, R., Felizarta, F., Fichtenbaum, C., Gallant, J., Gathe, J., Hagins, D., Henn, S., Henry, W.K., Huhn, G., Lucasti, C., Martorell, C., McDonald, C., Mills, A., Morales-Ramirez, J., Mounzer, K., Nahass, R., Olivet, H., Prelutsky, D., Ramgopal, M., Rashbaum, B., Richmond, G., Ruane, P., Scarsella, A., Scribner, A., Shalit, P., Shamblaw, D., Slim, J., Tashima, K., Ward, D., Wilkin, A., de Vente, J.

Volltext

Safety and exposure of once‐daily ritonavir‐boosted atazanavir in HIV‐infected pregnant women von Conradie, F, Zorrilla, C, Josipovic, D, Botes, M, Osiyemi, O, Vandeloise, E, Eley, T, Child, M, Bertz, R, Hu, W, Wirtz, V, McGrath, D

Volltext

Switching to the 2-drug regimen of dolutegravir/lamivudine von Llibre, J.M, Alves, C, Cheng, C-Y, Osiyemi, O, Galera, C, Hocqueloux, L, Maggiolo, F, Degen, O, Blair, E, Wynne, B, Oyee, J, Underwood, M, Curtis, L, Bontempo, G, van Wyk, J

Volltext

Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate... von Eron, Joseph J, Orkin, Chloe, Cunningham, Douglas, Pulido, Federico, Post, Frank A, De Wit, Stéphane, Lathouwers, Erkki, Hufkens, Veerle, Jezorwski, John, Petrovic, Romana, Brown, Kimberley, Van Landuyt, Erika, De Wit, S, Florence, E, Moutschen, M, Van Wijngaerden, E, Vandekerckhove, Linos, Vandercam, B, Conway, B, Klein, M, Murphy, D, Rachlis, A, Shafran, S, Walmsley, S, Ajana, F, Cotte, L, Girardy, P-M, Katlama, C, Molina, J-M, Rey, D, Reynes, J, Teicher, E, Yazdanpanah, Y, Gasiorowski, J, Halota, W, Horban, A, Piekarska, A, Witor, A, Arribas, JR, Casado, J, Gatell, JM, Gutierrez, F, Gutierrez, MDM, Iribarren, JA, Knobel, H, Negredo, E, Pineda, JA, Podzamczer, D, Portilla Sogorb, J, Pulido, F, Ricart, C, Rivero, A, Santos Gil, I, Blaxhult, A, Flamholc, L, Fehr, J, Rauch, A, Clarke, A, Gazzard, BG, Johnson, MA, Orkin, C, Post, F, Ustianowski, A, Waters, L, Bailey, J, Benson, P, Brar, I, Bredeek, UF, Brinson, C, Crofoot, G, Cunningham, D, DeJesus, E, Dietz, C, Dretler, R, Eron, J, Fichtenbaum, C, Gallant, J, Gathe, J, Hagins, D, Henn, S, Huhn, G, Jain, M, Lucasti, C, Martorell, C, McDonald, C, Mills, A, Mounzer, K, Olivet, H, Osiyemi, O, Prelutsky, D, Ramgopal, M, Richmond, G, Ruane, P, Scarsella, A, Shalit, P, Shamblaw, D, Voskuhl, G, Ward, D, Wilkin, A, de Vente, J

Volltext

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-bli... von NELSON, Mark, AMAYA, Gerardo, VANVEGGEL, Simon, BOVEN, Katia, CLUMECK, Nathan, DA CUNHA, Clovis Arns, JAYAWEERA, Dushyantha, JUNOD, Patrice, TAISHENG LI, TEBAS, Pablo, STEVENS, Marita, BUELENS, Annemie

Volltext

Safety, tolerability, and efficacy of raltegravir in a diverse cohort of HIV-infected patients: 48-week results from the REALMRK Study von Squires, Kathleen E, Bekker, Linda-Gail, Eron, Joseph J, Cheng, Benjamin, Rockstroh, Juergen K, Marquez, Farid, Kumar, Princy, Thompson, Melanie, Campo, Rafael E, Mounzer, Karam, Strohmaier, Kim M, Lu, Chengxing, Rodgers, Anthony, Jackson, Beth E, Wenning, Larissa A, Robertson, Michael, Nguyen, Bach-Yen T, Sklar, Peter

Volltext

Mechanical performance of carbon-fibre- and glass-fibre-reinforced epoxy I-beams: I. Mechanical behaviour von Gilchrist, M.D., Kinloch, A.J., Matthews, F.L., Osiyemi, S.O.

Volltext

Bonding method von Osiyemi, Stephen O, Thompson, Ewan F, Hicklin, Mark J

Volltext bestellen

BONDING METHOD von OSIYEMI Stephen O, HICKLIN Mark J, THOMPSON Ewan F

Volltext bestellen